Global surveillance and monitoring system for substandard and falsified medical products: activity report, August 2017-December 2021

Access to safe, effective medical products is paramount for global health. This report describes a critical role of WHO in ensuring the quality and safety of medical products, particularly in LMIC. The report signals the alarming rise in the number of reported incidents of SF medical products, including a wide range of essential medicines,

such as antimicrobials, oncology medicines and vaccines. During the period covered, 877 incidents were recorded, with an average annual increase of 36.3%. The potential impact on increase in antimicrobial resistance cannot be understated.